Tempest Therapeutics, Inc. (TPST) Financials

$7.13

$0 (0%)
Last update: 01:00 PM EST
Day's range
$7.07
Day's range
$7.18
$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning201820182019201920202020202120212022202220232023202420245%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

TPST Income statement / Annual

Last year (2024), Tempest Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Tempest Therapeutics, Inc.'s net income was -$41.84 M. See Tempest Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $295.00 K $653.00 K $277.00 K
Cost of Revenue $0.00 $381.00 K $0.00 $0.00 $0.00 $0.00 $32.00 K $28.00 K $5.40 M $2.25 M
Gross Profit $0.00 -$381.00 K -$1.81 M -$1.27 M -$815.00 K -$1.05 M -$32.00 K $267.00 K -$4.75 M -$1.97 M
Gross Profit Ratio 0 0 0 0 0 0 0 0.91 -7.27 -7.12
Research and Development Expenses $28.12 M $17.50 M $22.53 M $17.17 M $14.39 M $27.84 M $14.43 M $14.53 M $21.64 M $18.43 M
General & Administrative Expenses $13.55 M $11.66 M $12.11 M $9.82 M $4.91 M $17.56 M $8.69 M $27.74 M $49.22 M $51.59 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $16.50 M $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.55 M $11.66 M $12.11 M $9.82 M $4.91 M $16.50 M $8.66 M $5.93 M $49.22 M $51.59 M
Other Expenses $0.00 $0.00 $549.00 K -$34.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $42.03 M $28.78 M $34.64 M $26.99 M $19.30 M $44.35 M $23.08 M $20.45 M $70.86 M $70.03 M
Cost And Expenses $0.00 $29.16 M $34.64 M $26.99 M $19.30 M $45.40 M $23.12 M $20.48 M $76.27 M $72.28 M
Interest Income $0.00 $1.12 M $549.00 K $1.28 K $90.00 K $264.00 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $1.45 M $1.62 M $1.28 M $0.00 $0.00 $134.00 K $0.00 $659.00 K $436.00 K
Depreciation & Amortization $389.00 K $381.00 K $1.81 M $1.27 M $815.00 K $1.05 M $32.00 K $28.00 K $2.24 M $1.29 M
EBITDA -$40.14 M -$28.78 M -$32.28 M -$25.72 M -$18.39 M -$43.52 M -$27.01 M -$84.27 M -$79.82 M -$71.86 M
EBITDA Ratio 0 0 0 0 0 0 0 -285.66 -122.24 -259.42
Operating Income Ratio 0 0 0 0 0 0 0 -69.43 -124.06 -259.92
Total Other Income/Expenses Net $183.00 K -$334.00 K -$1.07 M -$1.32 M $90.00 K $831.00 K -$4.06 M -$64.10 M -$6.45 M -$1.15 M
Income Before Tax -$41.84 M -$29.49 M -$35.71 M -$28.30 M -$19.21 M -$44.57 M -$27.18 M -$84.59 M -$82.06 M -$73.14 M
Income Before Tax Ratio 0 0 0 0 0 0 0 -286.73 -125.66 -264.06
Income Tax Expense $0.00 $0.00 $1.07 M $1.25 M -$90.00 K $1.00 K -$169.00 K $67.00 K $201.00 K $75.00 K
Net Income -$41.84 M -$29.49 M -$35.71 M -$28.30 M -$19.12 M -$44.57 M -$27.19 M -$84.58 M -$82.26 M -$73.22 M
Net Income Ratio 0 0 0 0 0 0 0 -286.71 -125.97 -264.33
EPS -1.5 -1.91 -3.18 -7.8 -612.56 -48.77 -263.65 -72406.33 -575.73 -608.25
EPS Diluted -1.5 -1.91 -3.18 -7.8 -612.56 -48.77 -263.65 -72406.33 -575.73 -608.25
Weighted Average Shares Out $27.90 M $15.42 M $888.00 K $291.00 K $31.21 K $913.78 K $103.14 K $1.17 K $142.88 K $120.38 K
Weighted Average Shares Out Diluted $27.90 M $15.42 M $888.38 K $291.56 K $31.21 K $913.78 K $103.14 K $1.17 K $142.88 K $120.38 K
Link